Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS
Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $789.3 million versus the consensus estimate of $781.84 million.
Hologic sees FY2018 revenue of $3.18-3.21 million, versus the consensus of $3.25 million. Reiterating non-GAAP EPS guidance for the year.
For earnings history and earnings-related data on Hologic (HOLX) click here.